The ins and outs of short gut syndrome
| Saturday, May 30, 2026 |
| 2:00 PM - 2:45 PM |
| Royal Benowa Ballroom |
Overview
Jo Gross
Details
Following major bowel surgery, patients left with short gut syndrome experience significant impacts on their health and wellbeing. Their malabsorption of both nutrients and medicines requires a multidisciplinary approach. This session will touch on transitions of care, medication management of short gut syndrome and high output stoma, the impact of short gut syndrome on medication management, and the multidisciplinary team needed to support quality of life.
Learning Objectives
• Identify the how short gut syndrome affects medication absorption.
• Discuss the medication management strategies for short gut syndrome and high output stoma.
• Identify the role of consultant pharmacists and other health professionals working as a multidisciplinary team to support individuals living with short gut syndrome.
Competency Standards (2016): 3.1, 3.3, 3.5
Speaker
Joanne Gross
QUM Pharmacist
Department of Health Tasmania
The ins and outs of Short Gut Syndrome
Biography
Joanne is a Quality Use of Medicines Pharmacist at the Department of Health Tasmania part-time, an MMR Credentialed Pharmacist who conducts HMRs, and PSA Tasmanian Branch President.
Joanne spent her early career building her knowledge and expertise as a clinical pharmacist in regional and metropolitan hospitals across 3 states/territories and in medical information / pharmacovigilance roles in the UK and Australia.
During 9 years working as an NPS MedicineWise educational visitor, Jo completed a Master of Public Health, attained the US Board of Pharmaceutical Specialties (BPS) Geriatric Pharmacist credential and moved from Sydney to Melbourne to Hobart where she has planted roots in the shadows of kunanyi (Mt Wellington).
Most recently, Jo has kept busy completing a Graduate Certificate of Diabetes Education and supervising two Honours Students for the Monash SPHERE Centre for Research Excellence researching pharmacist's roles in the provision of reproductive healthcare.
Jo is also a member of the PSA Consultant Pharmacist Community of Special Interest (CSI) Leadership Committee and the CPC26 Organising Committee